- Home
- CLW vs ARCT Comparison
CLW vs ARCT Comparison
Compare CLW & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLW | ARCT |
|---|---|---|
| Founded | 1926 | 2013 |
| Country | United States | United States |
| Employees | 3710 | N/A |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 216.4M | 245.4M |
| IPO Year | 2008 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CLW | ARCT |
|---|---|---|
| Price | $13.64 | $7.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 10 |
| Target Price | $20.33 | ★ $24.11 |
| AVG Volume (30 Days) | 186.0K | ★ 382.5K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,555,400,000.00 | $82,031,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.16 | $12.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.42 | N/A |
| 52 Week Low | $11.73 | $5.85 |
| 52 Week High | $30.96 | $24.14 |
Technical Indicators
Market Signals| Indicator | CLW | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 33.55 |
| Support Level | $12.09 | $6.90 |
| Resistance Level | $14.56 | $7.88 |
| Average True Range (ATR) | 0.74 | 0.64 |
| MACD | -0.00 | -0.22 |
| Stochastic Oscillator | 64.31 | 2.28 |
Price Performance
Historical ComparisonAbout CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.